๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current practice of chronic hepatitis B treatment in Southern Italy

โœ Scribed by T. Stroffolini; A. Spadaro; V. Di Marco; G. Scifo; M. Russello; G. Montalto; G. Bertino; L. Surace; B. Caroleo; G. Foti; V. Portelli; S. Madonia; M. Sapienza; L. Cosco; P. Frugiuele; A. Galdieri; N. Brandolino; R. Siciliano; S. Bruno; P.L. Almasio

Book ID
116432747
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
147 KB
Volume
23
Category
Article
ISSN
0953-6205

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

AASLD practice guidelines on chronic hep
AASLD practice guidelines on chronic hepatitis B and HBV infection in Italy
โœ Tommaso Stroffolini; Giovanni Battista Gaeta; Alfonso Mele ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB

We thank Fazili et al. for their interest in our article. The development of antibodies to hepatitis B e antigen (anti-HBe) and hepatitis B surface antigen (anti-HBs) were lower in the lamivudine-treated group relative to placebo, although these did not reach statistical significance. We concur with

Treatment of chronic hepatitis B
Treatment of chronic hepatitis B
โœ Stephanie D. Straley; Norah A. Terrault ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 378 KB
Treatment of chronic hepatitis B: curren
Treatment of chronic hepatitis B: current challenges and future directions
โœ Ruth Chin; Stephen Locarnini ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 222 KB

## Abstract The clinical management of chronic hepatitis B infection has entered a new era with the introduction and widespread use of oral nucleoside analogues such as lamivudine and nucleotides such as adefovir dipivoxil. From this, new challenges have now emerged in terms of preventing antiviral